1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Hyperostosis: new trials by email Literature Review of Hyperostosis trials Research Report on Hyperostosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Efficacy and Safety Study of Palovarotene for the Treatment of MO Palovarotene 2.5 mg, Palovarotene 5.0 mg, Placebo - Exostoses, Multiple Hereditary | Phase 2 | Terminated | Clementia Pharmaceuticals Inc. | 193 | 2018-03-22 | 2022-08-01 |
Exostoses, Multiple Hereditary (1) · Osteochondroma (1)
Bone Diseases (1) · Bone Diseases, Developmental (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Exostoses (1) · Genetic Diseases, Inborn (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Bone Tissue (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplastic Syndromes, Hereditary (1) · Osteochondrodysplasias (1) · Osteochondromatosis (1)
Palovarotene (1)
Clementia Pharmaceuticals Inc. (1)
Australia (1) · Belgium (1) · Canada (1) · France (1) · Italy (1) · Japan (1) · Netherlands (1) · Portugal (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
2017 (1)